Intrinsic macrolide resistance in rapidly growing mycobacteria

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 10, 2006, Pages 3476-3478

  Nash, Kevin A ^a,c   Andini, Nadya ^a   Zhang, Yansheng ^b   Brown Elliott, Barbara A ^b   Wallace Jr , Richard J ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

^c CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; CLARITHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN; HMR 3004; KETOLIDE; MACROLIDE; MIKAMYCIN B; QUINUPRISTIN; SPIRAMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; ERM GENE; GENE SEQUENCE; MYCOBACTERIUM; MYCOBACTERIUM BOENICKEI; MYCOBACTERIUM GOODII; MYCOBACTERIUM HOUSTONENSE; MYCOBACTERIUM MAGERITENSE; MYCOBACTERIUM NEWORLEANSENSE; MYCOBACTERIUM PORCINUM; MYCOBACTERIUM WOLINSKYI; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SPECIES;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; DRUG RESISTANCE, BACTERIAL; HUMANS; MACROLIDES; METHYLTRANSFERASES; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM; SEQUENCE ANALYSIS, DNA;

EID: 33749509731     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00402-06     Document Type: Article

References (13)

1. Altschul, S. F., W. Gish, W. Miller, E. W. Myers, and D. J. Lipman. 1990. Basic local alignment search tool. J. Mol. Biol. 215:403-410.
2. Brown, B. A., B. Springer, V. A. Steingrube, R. W. Wilson, G. E. Pfyffer, M. J. Garcia, M. C. Menendez, B. Rodriguez-Salgado, K. C. Jost, Jr., S. H. Chiu, G. O. Onyi, E. C. Bottger, and R. J. Wallace, Jr. 1999. Mycobacterium wolinskyi sp. nov. and Mycobacterium goodii sp. nov., two new rapidly growing species related to Mycobacterium smegmatis and associated with human wound infections: a cooperative study from the International Working Group on Mycobacterial Taxonomy. Int. J. Syst. Bacteriol. 49:1493-1511.
3. Brown-Elliott, B. A., D. E. Griffith, and R. J. Wallace, Jr. 2002. Newly described or emerging human species of nontuberculous mycobacteria. Infect. Dis. Clin. N. Am. 16:187-220.
4. Brown-Elliott, B. A., and R. J. Wallace, Jr. 2002. Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria. Clin. Microbiol. Rev. 15:716-746.
5. CDC. 1999. Nontuberculous mycobacteria reported to the public health laboratory information system by state public health laboratories United States, 1993-1996. Centers for Disease Control and Prevention, Atlanta, Ga.
6. Devulder, G., M. Perouse de Montclosand, and J. P. Flandrois. 2005. A multigene approach to phylogenetic analysis using the genus Mycobacterium as a model. Int. J. Syst. Evol. Microbiol. 55:293-302.
7. Meinhart, A., J. C. Alonso, N. Strater, and W. Saenger. 2003. Crystal structure of the plasmid maintenance system epsilon/zeta: functional mechanism of toxin zeta and inactivation by epsilon 2 zeta 2 complex formation. Proc. Natl. Acad. Sci. USA 100:1661-1666.
8. Nash, K. A. 2003. Intrinsic macrolide resistance in Mycobacterium smegmatis is conferred by a novel erm gene, erm(38). Antimicrob. Agents Chemother. 47:3053-3060.
9. Nash, K. A., Y. Zhang, B. A. Brown-Elliott, and R. J. Wallace, Jr. 2005. Molecular basis of intrinsic macrolide resistance in clinical isolates of Mycobacterium fortuitum. J. Antimicrob. Chemother. 55:170-177.
10. NCCLS. 2003. Susceptibility testing of Mycobacteria, Nocardia, and other aerobic actinomycetes, 1st ed. Approved standard M24-A, vol. 23. NCCLS, Villanova, Pa.
11. Roberts, M. C. 21 February 2005, accession date. Nomenclature Center for MLS Genes. [Online.] http://faculty.washington.edu/marilynr/.
12. Roberts, M. C., J. Sutcliffe, P. Courvalin, L. B. Jensen, J. Rood, and H. Seppala. 1999. Nomenclature for macrolide and macrolide-lincosamide- streptogramin B resistance determinants. Antimicrob. Agents Chemother. 43:2823-2830.
13. Wallace, R. J., Jr. 1997. J. Glassroth, D. E. Griffith, K. N. Olivier, J. L. Cook, and F. Gordin. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am. J. Respir. Crit. Care Med. 156:1S-25S.